Urinary lithiasis and indinavir sulfate in HIV-infected patients: 4 cases.

被引：0
|
作者：
Chefchaouni, MC [1 ]
Thiounn, N [1 ]
Flam, T [1 ]
Zerbib, M [1 ]
Debre, B [1 ]
机构：
[1] Hop Cochin, Urol Clin, F-75679 Paris 14, France
来源：
JOURNAL D UROLOGIE | 1997年 / 103卷 / 1-2期
关键词：
urinary stones; iatrogenic; AIDS; VIH;
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
We report on 4 cases of urinary stone observed in patients treated with the drug Crixivan(R) (Indinavir Sulfate) and review the literature. Comments include stone composition, clinical aspects, treatment and prevention.
引用
收藏
页码：35 / 36
页数：2
相关论文
共 50 条
  • [1] Urinary cytology associated with human polyomavirus and indinavir therapy in HIV-infected patients
    Filie, AC
    Wilder, AM
    Brosky, K
    Kopp, JB
    Miller, KD
    Abati, A
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2002, 117 (06) : 922 - 926
  • [2] Nephrolithiasis in HIV-infected patients treated with indinavir
    Rodriguez-Rosado, R
    Jimenez-Nacher, I
    Valencia, E
    Soriano, V
    Gonzalez-Lahoz, JG
    ANTIVIRAL THERAPY, 1998, 3 (02) : 113 - 113
  • [3] Aseptic osteonecrosis in HIV-infected patients: A retrospective study of 13 cases.
    Farrenq, V
    Rosenberg, S
    Valentin, MA
    Tubiana, R
    Katlama, C
    Bourgeois, P
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S526 - S526
  • [4] Effect of indinavir on the pharmacokinetics of rifampicin in HIV-infected patients
    Jaruratanasirikul, S
    Sriwiriyajan, S
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2001, 53 (03) : 409 - 412
  • [5] Pharmacokinetics of indinavir in HIV-infected children
    Burger, DM
    Hugen, PWH
    de Groot, R
    AIDS, 1998, 12 : S10 - S10
  • [6] Pharmacokinetics of indinavir in HIV-infected children
    Burger, DM
    Hugen, PWH
    de Groot, R
    AIDS, 1998, 12 : S93 - S93
  • [7] Indinavir-associated facial lipodystrophy in HIV-infected patients
    Ho, TTY
    Chan, KCW
    Wong, KH
    Lee, SS
    AIDS PATIENT CARE AND STDS, 1999, 13 (01) : 11 - 16
  • [8] Treatment of recurring cutaneous drug reactions in HIV-infected patients: A series of five cases.
    Dolev, JC
    Reyter, I
    Maurer, T
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P56 - P56
  • [9] Continued indinavir versus switching to indinavir/ritonavir in HIV-infected patients with suppressed viral load
    Arnaiz, JA
    Mallolas, J
    Podzamczer, D
    Gerstoft, J
    Lundgren, JD
    Cahn, P
    Fätkenheuer, G
    D'Arminio-Monforte, A
    Casiró, A
    Reiss, P
    Burger, DM
    Stek, M
    Gatell, JM
    AIDS, 2003, 17 (06) : 831 - 840
  • [10] Therapeutic drug monitoring of indinavir in HIV-Infected patients undergoing HAART
    Langmann, R
    Zilly, M
    Weissbrich, B
    Desch, S
    Väth, T
    Klinker, H
    INFECTION, 2002, 30 (01) : 13 - 16
12345